Tezspire wins EU approval for chronic rhinosinusitis with nasal polyps
Go back to Tezspire wins EU approval for chronic rhinosinusitis with nasal polyps| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $415.21 | 52 Week High | $176.85 | |||
| Open | $415.21 | 52 Week Low | $133.64 | |||
| Day High | $415.21 | P/E | 62.53 | |||
| Day Low | $415.21 | EPS | $6.64 | |||
| Volume | 2,638 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 43,991 | |||||
